The third phase of Zhongshan Life Science Park broke ground in Cuiheng New District on June 12. With a total investment exceeding 100 million yuan, the project will become a leading domestic headquarters base for medical device companies.

The project will feature a modern six-story facility, housing an R&D center, an innovation center, a high-value consumables production base, and office space. The main structure is slated for completion in 2027.

Once completed, the park will focus on R&D and production in two high-end medical device fields: neurointervention and structural heart disease. Annual output will reach 50,000 units of neurointerventional consumables and 10,000 sets of structural heart disease consumables.